OncoAlert Colloquium Day 5: Genitourinary tumours and social media
Published: 23 Dec 2020
Views: 286
Dr McBride, Dr Apolo, Dr Choueiri, Dr Morgan, Dr Agarwal
We present Day 5 of the OncoAlert Colloquium 2020 cancer roundups.
Day 5 features presentations on genitourinary tumours, and a special presentation on the use of social media with oncology
- Categories:
- Prostate & urology
- Patient empowerment
- Personalised medicine
- Psychosocial
- Care
- Economics
- Global health & cancer
- Low-middle income
- Medicines
- Organisation of cancer
- Prevention
- R&D
- Regulatory
- Science domains
- Social determinants
- Technology & innovation
- Training & development
- Bioinformatics
- Biology
- Biomarkers
- Causes of cancer
- Control, survivorships & outcomes
- Detection, diagnosis & prognosis
- Devices
- Diagnostics
- Epidemiology & prevention
- Imaging
- Screening
- Antibodies & immunotherapy
- Cell therapy & stem cells
- Complications
- Cytotoxics
- Drug development
- Hormones/endocrine
- Radiotherapy
- Supportive care
- Surgery
- Targeted molecules
- Transplantation
- Vaccines & virus
Related Videos
Mitomycin and BCG treatment vs BCG monotherapy in patients with non-muscle invas...
Dr Cosimo De Nunzio - Sant'Andrea Hospital, University La Sapienza, Rome, Italy
19 Jul 2021
Long term outcome of enfortumab vedotin + pembrolizumab in first line locally ad...
Dr Terence Friedlander - UCSF, San Francisco, USA
4 Jun 2021
Latest in EGFR-positive NSCLC with exon 20 insertion mutations
Prof Sanjay Popat, Prof Michael Thomas, Dr Marina Garassino, Dr Rosario Campelo,...
9 Feb 2021
Updates on criteria for patient selection and surgical management in advanced ov...
Prof Pedro Ramirez - MD Anderson Cancer Center, Houston, USA
20 Jan 2021
How to improve cancer prevention and screening programmes in Romania
Dr Răzvan Curcă - Alba Iulia Emergency Hospital, Alba Iulia, Romania
19 Jan 2021
PARP inhibitors for prostate cancer - Nurse's view
Laurie M. Connors - Vanderbilt University School of Nursing, Nashville, USA
24 Nov 2020
Key themes, highlights and importance of this year's IBCD 2020 meeting
Dr Roberto Salgado - Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgiu...
29 Oct 2020
PARP inhibitors and their evolving role for the treatment of prostate cancer
Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi
24 Sep 2020
IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial c...
Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA
30 Jun 2020
